Sirio to launch new BloomDays postbiotic gummies

Published: 15-Feb-2024

The company will launch the novel gummies at Expo West 2024

Sirio Pharma Co., Ltd. (Sirio), a global manufacturer of nutritional supplements, is launching BloomDays, a first-to-market postbiotic gummy product featuring EpiCor, Cargill’s postbiotic ingredient.

BloomDays targets immune health and the growing gut health segment by combining Sirio’s development and manufacturing capabilities with the science-backed ingredient, EpiCor. 

EpiCor postbiotic is an ingredient from whole food yeast fermentate, backed by 8 human and 8 pre-clinical studies that demonstrate its effectiveness in supporting immune health and positively modulating the gut microbiome.

Sirio’s BloomDays postbiotic gummies meet current consumer demands for health- conscious and sustainable choices. 

"BloomDaysTM represents a milestone in our commitment to collaborating with reputable ingredients suppliers to launch solutions for our customers, helping them win in the market.” said Sara Lesina, General Manager Europe and Americas at Sirio.

The official launch will be held at Expo West 2024, hosted at the Anaheim Convention Center from March 14, 2024, to March 16, 2024. 

Attendees are invited to see the product for themselves at  Booth #3905, where Sirio will showcase the features and benefits of this new offering. 
Sirio also plans to launch the product in Europe in the second half of 2024 at CPHI Milan.


You may also like